Rodman & Renshaw downgrades Pharmacopeia (Nasdaq: PCOP) from Market Outperform to Market Perform.

Rodman analyst says, "On ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE